Wednesday, December 19, 2012

Company announcements: AscendasHT, TianjinZUS$

AscendasHT - MISCELLANEOUS :: COMPLETION OF ACQUISITION OF IBIS BEIJING SANYUAN

Announcement Type: MISCELLANEOUS
Company: ASCENDAS HOSPITALITY TRUST
Stock Code/Name: Q1P - AscendasHT

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * ASCENDAS HOSPITALITY TRUST  
Company Registration No. N.A.  
Announcement submitted on behalf of ASCENDAS HOSPITALITY TRUST  
Announcement is submitted with respect to * ASCENDAS HOSPITALITY TRUST  
Announcement is submitted by * Ms Mary J. de Souza  
Designation * Company Secretary  
Date & Time of Broadcast 19-Dec-2012 17:17:54  
Announcement No. 00041  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * Completion Of Acquisition Of Ibis Beijing Sanyuan  
Description
   
Attachments
Total size = 134K
(2048K size limit recommended)


TianjinZUS$ - ANNOUNCEMENT OF APPOINTMENT OF NON-EXECUTIVE DIRECTOR

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: TIANJIN ZHONG XIN PHARM GROUP
Stock Code/Name: T14 - TianjinZUS$

ANNOUNCEMENT OF APPOINTMENT OF NON-EXECUTIVE DIRECTOR *
* Asterisks denote mandatory information
Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
Company Registration No. 120000000004711  
Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted by * Jiao Yan  
Designation * Secretary to the Board  
Date & Time of Broadcast 19-Dec-2012 17:23:04  
Announcement No. 00046  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Date of Appointment * 18-12-2012  
Name of Person* Ma Gui Zhong  
Age * 57  
Country of principal residence * China  
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * approve of the decision  
Whether appointment is executive, and if so, the area of responsibility *
Non-Executive Director  
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Non-Executive Director and Strategic Committee Member  
Working experience and occupation(s) during the past 10 years *
He has been a section member, supervisory section member, Deputy Director and Director of the Finance Department of Tianjin Pharmaceutical Bureau. Current, he is holding the position of the Member of the Party Committee, Deputy General Manager, Chief Accountant and General Legal Counsel of Tianjin Pharmaceutical Group Co. Ltd. He is a Supervisor of the Board of Supervisors of the Company since May 1999.  
Interest * in the listed issuer and its subsidiaries *
NIL  
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
NIL  
Conflict of interests (including any competing business) *
NIL  
>> OTHER DIRECTORSHIP#
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
NIL  
Present
NIL  
>> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H)

Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given.

(a)*Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
  • No  

       


    • TianjinZUS$ - ANNOUNCEMENT OF CESSATION AS SUPERVISOR

    Announcement Type: ANNOUNCEMENT OF CESSATION
    Company: TIANJIN ZHONG XIN PHARM GROUP
    Stock Code/Name: T14 - TianjinZUS$

    ANNOUNCEMENT OF CESSATION AS SUPERVISOR *
    * Asterisks denote mandatory information
    Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
    Company Registration No. 120000000004711  
    Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted by * Jiao Yan  
    Designation * Secretary to the Board  
    Date & Time of Broadcast 19-Dec-2012 17:20:40  
    Announcement No. 00044  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Name of person * Ma Gui Zhong  
    Age * 57  
    Is Effective Date of Cessation known? * Yes  
    If yes, please provide the date * 18-12-2012  
    Detailed Reason(s) for cessation *
    job assignment change  
    Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No 
    If yes, please elaborate * NA 
    Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Any other relevant information to be provided to shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Date of Appointment to current position * 12-05-2005  
    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Supervisor  
    Role and responsibilities *
    Supervision work  
    Does the AC have a minimum of 3 members (taking into account this cessation)? *Yes 
    Number of Independent Directors currently resident in Singapore (taking into account this cessation) *2 
    Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months *2 
    Interest * in the listed issuer and its subsidiaries *
    NIL  
    Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
    NIL  
    >> OTHER DIRECTORSHIPS
    Past (for the last 5 years) *
    He has been a section member, supervisory section member, Deputy Director and Director of the Finance Department of Tianjin Pharmaceutical Bureau. Current, he is holding the position of the Member of the Party Committee, Deputy General Manager, Chief Accountant and General Legal Counsel of Tianjin Pharmaceutical Group Co. Ltd. He is a Supervisor of the Board of Supervisors of the Company since May 1999.  
    Present *
    NIL  
    Footnotes
       
    Attachments
    Total size = 0
    (2048K size limit recommended)


    TianjinZUS$ - ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR

    Announcement Type: ANNOUNCEMENT OF CESSATION
    Company: TIANJIN ZHONG XIN PHARM GROUP
    Stock Code/Name: T14 - TianjinZUS$

    ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR *
    * Asterisks denote mandatory information
    Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
    Company Registration No. 120000000004711  
    Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted by * Jiao Yan  
    Designation * Secretary to the Board  
    Date & Time of Broadcast 19-Dec-2012 17:17:51  
    Announcement No. 00040  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Name of person * Han Lu Lan  
    Age * 55  
    Is Effective Date of Cessation known? * Yes  
    If yes, please provide the date * 18-12-2012  
    Detailed Reason(s) for cessation *
    She will retire due to the statutory retirement age.  
    Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No 
    If yes, please elaborate * NA 
    Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Any other relevant information to be provided to shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Date of Appointment to current position * 31-01-2007  
    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Executive Director  
    Role and responsibilities *
    Responsible for drug production.  
    Does the AC have a minimum of 3 members (taking into account this cessation)? *Yes 
    Number of Independent Directors currently resident in Singapore (taking into account this cessation) *2 
    Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months *2 
    Interest * in the listed issuer and its subsidiaries *
    NIL  
    Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
    NIL  
    >> OTHER DIRECTORSHIPS
    Past (for the last 5 years) *
    From September 2001 to September 2003, she was the secretary to the party’s committee of Tianjin Zhong Xin No. 6 Pharmaceutical Plant; she has been appointed as the secretary to the party’s committee cum deputy head of Tianjin Zhong Xin No. 6 Pharmaceutical Plant since September 2003.  
    Present *
    NIL  
    Footnotes
       
    Attachments
    Total size = 0
    (2048K size limit recommended)


    TianjinZUS$ - ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR

    Announcement Type: ANNOUNCEMENT OF CESSATION
    Company: TIANJIN ZHONG XIN PHARM GROUP
    Stock Code/Name: T14 - TianjinZUS$

    ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR *
    * Asterisks denote mandatory information
    Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
    Company Registration No. 120000000004711  
    Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted by * Jiao Yan  
    Designation * Secretary to the Board  
    Date & Time of Broadcast 19-Dec-2012 17:14:32  
    Announcement No. 00036  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Name of person * Zhang Ping  
    Age * 43  
    Is Effective Date of Cessation known? * Yes  
    If yes, please provide the date * 18-12-2012  
    Detailed Reason(s) for cessation *
    job assignment change  
    Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No 
    If yes, please elaborate * NA 
    Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Any other relevant information to be provided to shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Date of Appointment to current position * 28-12-2007  
    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Executive Director  
    Role and responsibilities *
    in charge of Investment and technique management  
    Does the AC have a minimum of 3 members (taking into account this cessation)? *Yes 
    Number of Independent Directors currently resident in Singapore (taking into account this cessation) *2 
    Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months *2 
    Interest * in the listed issuer and its subsidiaries *
    NIL  
    Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
    NIL  
    >> OTHER DIRECTORSHIPS
    Past (for the last 5 years) *
    From March 2002 to November 2006, he was Assistant General Manager of Company. He has been the Deputy General Manager cum Chief Engineer of the Company since November 2006.  
    Present *
    NIL  
    Footnotes
       
    Attachments
    Total size = 0
    (2048K size limit recommended)


    Labels: ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)